Rudy Mazzocchi Releases the 2nd Novel in Series, EQUITY of FEAR

The first book in The EQUITY Series, EQUITY of EVIL, quickly catapulted to the top of the charts on Amazon as the #1 Medical Thriller based on Average Customer Reviews. Three literary awards, including the 2012 Global eBook Award for Best Suspense Thriller, further enhanced the brand recognition of this debut novel. With growing momentum in a competitive industry, Mazzocchi is quickly following with the release of his second novel that seems to promise the same suspense, intensity and international intrigue.

EQUITY of FEAR, published by Twilight Times Books (Kingsport, TN), was released on March 25, 2013 in eBook format and will be available as a print edition in July. As with the first thriller in this series, EQUITY of EVIL, Mazzocchi once again pulls from personal business experiences to build a story of suspense - this time based on the medical science of neuroplasticity, the rewiring of the brain.

Synopsis of EQUITY of FEAR:

Researchers and scientists in the U.S., Russia and Japan compete in a new technological race to control fear and pain in the minds of the world's populace. At first, the race is rooted in purely scientific ambitions, such as that of space travel or in the era of industrial revolution, but it evolves into something much more sinister.

What might governments or powerful organizations do or pay for the keys to control the fear of pain or the fear of death? What limits would prevent them from eliminating anything or anyone standing in the way? How far would they go to control the monopoly over a technology that could subliminally control the human brain, and what power would they have over the lives of billions, if successful?

Here is yet another dark world where scientists experiment on orphaned children rather than rhesus monkeys, where torture and pain become just another set of data points and lives are discarded for the sake of owning the ability to control how man perceives and processes fear.

Book Trailer: http://bit.ly/11nFRHv

About Mazzocchi:

Rudy is best known as a medical device and biotechnology entrepreneur, inventor, and angel investor, with a history of starting new technology ventures throughout the U.S. and Europe. He's been privileged to have the opportunity to see the newest innovations in healthcare and work with some of the most brilliant researchers, scientists and physicians in the industry.

Authoring more than 50 patents, he has helped pioneer new companies involved in cardiology, oncology, orthopedics, neurosurgery and even embryonic stem-cell development. Through these efforts, he has become the recipient of many technology and business awards, including the Ernst & Young Entrepreneur of the Year Award in Healthcare and the National Businessman of the Year Award.

Combining these experiences and opportunities, with thousands of hours of travel and long evenings in hotel rooms, he found the initiative to start writing a collection of medical thrillers based on true events, now referred to as The EQUITY Series.

To post a comment, you must register and login.